logo
16:01 Dec 05

Vivo Bio Tech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
28.21
-1.93 (-6.40%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Vivo Bio Tech Ltd. Financials

Vivo Bio Tech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
28.21
-1.93 (-6.40%)
16:01 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

57/100
Affordable Valuation

Technical

31/100
Technically Bearish

Strength

6

Weakness

10

Opportunity

0

Threats

0

9.34 %

ROE %

5.08 %

ROA %

0.00

EPS

45.39

BVPS

15.60 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
51.39 52.23 45.45 46.67 50.12
Operating Expenses +
35.58 30.73 24.36 26.16 28.65
Raw Material
7.97 4.93 4.65 4.81 5.13
Increase Decrease in Cost
3.47 1.84 -0.8 0.98 1.1
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
9.42 13.52 10.68 12.14 13.64
Miscellaneous Expenses
30.66 20.3 19.13 17.85 8.78
Operating Profit
15.81 21.5 21.09 20.51 21.47
Other Income
0.1 0.04 0.04 4.8 0.43
Depreciation
7.45 9.27 9.29 9.02 9.14
Interest
3.99 7.65 7.78 7.5 7.06
Profit before tax and exceptio..
4.47 4.62 4.06 8.79 5.7
Exceptional Items
0 0 0 0 0
PBT
4.47 4.62 4.06 8.79 5.7
Provision for Taxation
2.27 1.97 1.53 1.51 1.6
Net Profit
2.2 2.65 2.53 7.28 4.09
NET Profit after MI
2.2 2.65 2.53 7.28 4.09
EPS
1.56 1.78 1.7 4.76 2.43
Operating Profit Margin (%)
30.76 41.16 46.4 43.95 42.84
Net Profit Margin (%)
4.28 5.07 5.57 15.6 8.16

Vivo Bio Tech Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 35.20 39.10 40.80 38.90 42.10 42.10
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 64.80 60.90 59.20 61.10 57.90 57.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: